Latest stories on VRDN
Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)
Yahoo Top68 · bullishanalyst
Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone
Yahoo Finance68 · bullishanalyst
Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease - Slideshow
Seeking Alpha73 · bullishproduct/pr
Viridian Therapeutics: Lumvoa Ready For Prime Time Following FDA Approval
Seeking Alpha78 · bullishproduct/pr
Viridian Therapeutics, Inc. (VRDN) Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease Transcript
Seeking Alpha73 · bullishproduct/pr
Biggest stock movers Monday: GME, BTI, and more
Seeking Alpha55 · neutralgeneral
Viridian launches first commercial product as U.S. approves thyroid eye disease therapy
Seeking Alpha73 · bullishproduct/pr
Viridian Therapeutics Says FDA Approves Lumvoa to Treat Thyroid Eye Disease
Morningstar78 · bullishproduct/pr
VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval
Stocktwits News71 · bullishproduct/pr
Viridian Therapeutics, Inc.\DE (VRDN) files 8-K
SEC 8-K50 · neutralgeneral
Viridian Therapeutics: A Two-Step TED Franchise With More Leverage Than The Market Appreciates
Seeking Alpha67 · bullishanalyst
Viridian Therapeutics, Inc. (VRDN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha56 · neutralgeneral
Viridian Therapeutics Fully Repays Loan, Ends Agreement
TipRanks63 · neutralgeneral
Viridian Therapeutics to Participate in Upcoming June Investor Conferences | VRDN Stock News
StockTitan56 · neutralgeneral
Viridian Therapeutics secures WuXi deal for veligrotug manufacturing
TipRanks63 · neutralgeneral
Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M
Yahoo Finance24 · bearishgeneral
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
Yahoo Finance42 · neutralgeneral
Viridian (VRDN) Climbs 33% on Looming Drug Commercialization
Yahoo Finance73 · bullishproduct/pr
PDUFA Decision Nears as Viridian Therapeutics (VRDN) Advances TED Pipeline and Reports Q1 Results
Yahoo Finance56 · neutralproduct/pr